We have not found any cost information for this lawyer
Paul Andrew Braier
Claim Profile
Is this your profile? Claiming it is free and only takes 2 minutes.
About Paul
Practice Areas
1
Practice Area
Fees and Rates
Looking for an attorney? Avvo can help.
Search our directory
Quickly connect with top attorneys through our legal directory to get help with your legal issue.
Avvo's live chat agents can help coordinate a consultation with a local attorney.
Chat with a live agent who can match you with the right attorney for your legal needs.
Chat withLicenses
Licensed in Virginia for 26 years
State: Virginia
Acquired: 1999
No misconduct found
Location
Greenblum & Bernstein, P.L.C.
1950 Roland Clarke Place, Reston, VA, 20191
Law Offices of Paul Andrew Braier
Reston, VA, 20191-1405
Ad
Transform legal challenges into solutions.
Connect now to review your situation.
Paul Andrew Braier's Reviews
Avvo Review Score
Not Yet Reviewed
Paul Andrew Braier's Lawyer Endorsements
No Endorsement Data Available Yet
This attorney hasn't received any attorney endorsements recently on Avvo.
No Endorsement Data Available Yet
This attorney hasn't created any attorney endorsements recently on Avvo.
Experience
Associations
Virginia State Bar
Member
Education
1998
Georgetown University Law Center
JD - Juris Doctor
1992
University of Chicago
PhD - Doctorate
1986
College of William and Mary
BS - Bachelor of Science
Publications
2009
Journal of Generic Medicines
Recent Cases Highlight Shortcomings and Inconsistencies in the Law: In re Ciprofloxacin; Celgene v. KV and SB Pharmco v. Mutual
2008
The Pharmaceutical Regulatory Process
Generic Drugs in a Changing Intellectual Property Landscape
2008
Journal of Generic Medicines
Federal Circuit Abandons ‘Affirmative Duty of Due Care’ Willful Infringement Standard and Clarifies the Scope of Waiver Resulting m the ‘Advice of Counsel’ Defense
2008
Journal of Generic Medicines
Acarbose: A Case Study in the Forfeiture of the 180-Day Exclusivity
2007
Journal of Generic Medicines
Indirect Patent Infringement in the U.S.: Points to Consider for Generic and API Manufacturers